1. Home
  2. VRAX vs SNTG Comparison

VRAX vs SNTG Comparison

Compare VRAX & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • SNTG
  • Stock Information
  • Founded
  • VRAX 2013
  • SNTG 2009
  • Country
  • VRAX United Kingdom
  • SNTG China
  • Employees
  • VRAX N/A
  • SNTG N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SNTG Finance: Consumer Services
  • Sector
  • VRAX Health Care
  • SNTG Finance
  • Exchange
  • VRAX Nasdaq
  • SNTG Nasdaq
  • Market Cap
  • VRAX 4.7M
  • SNTG 4.8M
  • IPO Year
  • VRAX 2022
  • SNTG 2021
  • Fundamental
  • Price
  • VRAX $0.79
  • SNTG $1.82
  • Analyst Decision
  • VRAX Strong Buy
  • SNTG
  • Analyst Count
  • VRAX 1
  • SNTG 0
  • Target Price
  • VRAX $3.00
  • SNTG N/A
  • AVG Volume (30 Days)
  • VRAX 38.7K
  • SNTG 6.5K
  • Earning Date
  • VRAX 02-05-2025
  • SNTG 07-07-2025
  • Dividend Yield
  • VRAX N/A
  • SNTG N/A
  • EPS Growth
  • VRAX N/A
  • SNTG N/A
  • EPS
  • VRAX N/A
  • SNTG N/A
  • Revenue
  • VRAX $84,872.00
  • SNTG $107,507.00
  • Revenue This Year
  • VRAX $5,169.18
  • SNTG N/A
  • Revenue Next Year
  • VRAX $66.97
  • SNTG N/A
  • P/E Ratio
  • VRAX N/A
  • SNTG N/A
  • Revenue Growth
  • VRAX 7.03
  • SNTG N/A
  • 52 Week Low
  • VRAX $0.74
  • SNTG $1.43
  • 52 Week High
  • VRAX $9.00
  • SNTG $3.97
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 31.75
  • SNTG 54.53
  • Support Level
  • VRAX $0.75
  • SNTG $1.67
  • Resistance Level
  • VRAX $0.85
  • SNTG $1.92
  • Average True Range (ATR)
  • VRAX 0.07
  • SNTG 0.09
  • MACD
  • VRAX -0.01
  • SNTG 0.01
  • Stochastic Oscillator
  • VRAX 6.57
  • SNTG 62.96

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

Share on Social Networks: